[Inhibition of the proteolytic activity of Helicobacter pylori by mouse immune serum]
R González Segovia1, M Montañez Díaz, J E Armenta Yaumer
1Departamento de Microbiología, Centro de Ciencias Básicas de la Universidad Autónoma de Aguascalientes, Avenida Universidad No. 940, C.P. 20100, Aguascalientes, México. rgonzals@correo.uaa.mx
Abstract:
The proteolytic activity (PA) of some microorganisms is an important pathogenic factor during tissue invasion. However, its role in Helicobacter pylori infection is not clear. Due to the importance of the immunological response to inhibit pathogenic factors of microorganisms, this study aims to establish an in vitro system to detect inhibitory antibodies to the PA of H. pylori in mouse serum. We obtained mouse sera from animals immunized by oral and intraperitoneal inoculations with the raw bacterial extract (BE) of H. pylori, in which we had previously detected PA. The degradation of azocasein subtract for BE was inhibited in 49.23% and 22.6% using 5 micrograms/ml of serum proteins (SP) from oral and intraperitoneal inoculation, respectively. However, when using more than 25 micrograms/ml of SP of immune serum, PA was inhibited in a similar way than with control serum. In conclusion we present a methodology for the detection of inhibitory antibodies to PA of H. pylori in the serum of the immunized mouse.
Insights
Researchers developed an in vitro method to detect antibodies inhibiting Helicobacter pylori proteolytic activity (PA). Mouse serum antibodies partially blocked PA, with oral immunization showing greater inhibition than intraperitoneal routes.
Area of Science:
- Microbiology and Immunology
- Pathogen-Host Interactions
Background:
- Proteolytic activity (PA) is a key virulence factor in microbial pathogenesis and tissue invasion.
- The specific role of PA in Helicobacter pylori infections and the host's immune response remain incompletely understood.
Purpose of the Study:
- To establish an in vitro system for detecting antibodies that inhibit the PA of Helicobacter pylori.
- To assess the efficacy of mouse serum antibodies generated through different immunization routes against H. pylori PA.
Main Methods:
- Mice were immunized via oral and intraperitoneal routes using a raw bacterial extract (BE) of H. pylori containing PA.
- Serum proteins (SP) from immunized mice were used to assess inhibition of azocasein degradation by H. pylori BE in vitro.
Main Results:
- Serum proteins from orally immunized mice inhibited H. pylori PA by 49.23% at 5 µg/ml, while intraperitoneally immunized mice showed 22.6% inhibition.
- At concentrations above 25 µg/ml, serum proteins from both immunization groups exhibited similar inhibition levels to control serum.
Conclusions:
- A novel methodology was successfully developed for detecting antibodies that inhibit H. pylori PA in immunized mouse serum.
- The findings suggest that oral immunization elicits a more potent inhibitory antibody response against H. pylori PA compared to intraperitoneal immunization.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology


